Clinical Trials Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4644-4651
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4644
Table 1 Patient demographics and disease characteristics n (%)
BaselineETV (n = 159)LAM (n = 146)
Age, mean ± SE, yr (range)35 ± 1.1 (17-76)34 ± 1.1 (16-71)
Male116 (73)104 (71)
Race
Asian92 (58)87 (60)
White64 (40)53 (36)
HBV genotype
A45 (28)41 (28)
B28 (18)28 (19)
C44 (28)36 (25)
D18 (11)23 (16)
F12 (8)5 (3)
Mixed4 (3)3 (2)
Indeterminate7 (4)8 (5)
Missing1 (< 1)2 (1)
Serum HBV DNA, mean ± SE, log10 IU/mL9.52 ± 0.169.66 ± 0.16
Hepatic HBV cccDNA, mean ± SE, log10 copies/HGEq1.90 ± 0.112.0 ± 0.11
Hepatic HBV DNA, mean ± SE, log10 copies/HGEq0.3 ± 0.050.4 ± 0.04
ALT (U/L)
mean ± SE134.9 (9.84)132.8 (10.07)
Median (range)96.0 (23.0-915.0)90.0 (27.0-715.0)
International normalized ratio1.1 (0.01)1.1 (0.01)
Albumin (g/dL)4.3 (0.04)4.2 (0.04)
Total bilirubin (mg/dL)0.8 (0.03)0.8 (0.03)
Prothrombin time (s)13.2 (0.16)13.3 (0.16)
Knodell necroinflammatory score, mean ± SE7.8 ± 0.237.5 ± 0.24
Ishak fibrosis score, mean ± SE2.4 ± 0.112.1 ± 0.11